Dabrafenib Interactions
There are 510 drugs known to interact with dabrafenib, along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 87 are major, 408 are moderate, and 15 are minor.
- View all 510 medications that may interact with dabrafenib
- View dabrafenib alcohol/food interactions (1)
- View dabrafenib disease interactions (7)
Most frequently checked interactions
View interaction reports for dabrafenib and the medicines listed below.
- Activated Charcoal (charcoal)
- Advil (ibuprofen)
- Cartia XT (diltiazem)
- Centrum Silver (multivitamin with minerals)
- Centrum Silver Men's (multivitamin with minerals)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Dextrose (glucose)
- DHEA (dehydroepiandrosterone)
- Diltiazem Hydrochloride SR (diltiazem)
- Glycerol (glycerin)
- Iodides (sodium iodide)
- Iron Sulfate (ferrous sulfate)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lithium Carbonate ER (lithium)
- Mekinist (trametinib)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Multi Vitamin+ (multivitamin)
- Novolog (insulin aspart)
- Paracetamol (acetaminophen)
- Quercetin (bioflavonoids)
- Valproate Sodium (valproic acid)
- Viagra (sildenafil)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Dabrafenib alcohol/food interactions
There is 1 alcohol/food interaction with dabrafenib.
Dabrafenib disease interactions
There are 7 disease interactions with dabrafenib which include:
Report options
More about dabrafenib
- dabrafenib consumer information
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Tafinlar
Tafinlar is a prescription medicine used to treat BRAF mutated melanoma, non-small cell lung ...
Mekinist
Mekinist is used to treat melanoma, non-small cell lung cancer, thyroid cancer, solid tumors, and ...
Yervoy
Yervoy (ipilimumab) is a cancer treatment used for lung cancer, melanoma, renal cell carcinoma ...
Mektovi
Mektovi (binimetinib) is an oral kinase inhibitor that may be used in combination with encorafenib ...
Ipilimumab
ipilimumab (Yervoy) is an immunotherapy used for melanoma, renal cell carcinoma, non-small cell ...
Dacarbazine
Dacarbazine is used for hodgkin's lymphoma, melanoma, melanoma, metastatic
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
